Antiviral protein that gives immune response to Zika viral infection in mothers may harm the placenta and fetal development, according to a study led by scientists at Yale. The findings of the study are published in the journal Science Immunology.
Zika scientists had established that these antiviral proteins, known as type I interferon, were required to fight Zika infection in mothers. But it was not clear what role interferon played in providing an immune defense for the fetus.
To investigate, the team led by immunobiologist Akiko Iwasaki studied two different types of mouse models. One type lacked the receptor for type 1 interferon altogether, and the other had only one copy of the interferon receptor gene. Only the latter showed signs of abnormal placental development, restricted fetal growth and death, the scientists said.